What does healthcare systems & technologies — royalty rate mean?

The percentage of sales paid to external parties for the right to use their technology or intellectual property.

How do you interpret healthcare systems & technologies — royalty rate?

A rising royalty rate may indicate increasing reliance on third-party technology, which can pressure long-term segment profitability.

How does healthcare systems & technologies — royalty rate compare across companies?

Commonly found in licensing agreements and cost-of-goods-sold analysis for technology-heavy medical device segments.

Baxter International BAX Healthcare Systems & Technologies — Royalty rate

Similar metrics at other companies

BMYRest of World Except Japan, South Korea and Taiwan — Royalty rate due to regulatory approvals

3.8%0.0pp

VRTXALYFTREK — Royalty burden, percentage

4%—

BMYNorth America — Royalty rate due to regulatory approvals

1%0.0pp

IONSOperating Segments — Royalty Revenue

$0-100%

IONSPelacarsen Active Pharmaceutical Ingredient — Percentage Of Royalty Payments Paid On Annual Sales Of Medicine

25%0.0pp

VICRRoyalty — Revenue

$14.97M+39.1%

Other financials

Income statement

See full

Revenue$2.7B+2.9%

Gross profit$891.0M+3.5%

Operating income$66.0M+13.8%

Net income-$15.0M-112%

EPS (diluted)-$0.03-112%

Balance sheet

See full

Cash & equivalents$2.0B-12.1%

Total debt$224.0M-8.9%

Total equity$6.0B-14.7%

Total assets$19.8B-6.8%

Cash flow

See full

Operating cash flow$213.0M+210%

CapEx$128.3M+15.0%

Free cash flow$83.0M-42.1%

Valuation

See full

Market cap$10.27B-50.6%

Enterprise value$8.48B-55.6%

P/S0.9×-1.0×

Profitability

See full

Gross margin30.1%-5.9pp

Operating margin-2.7%—

Net margin-9.7%+62.5pp

FCF margin3%-2.4pp

Returns & leverage

See full

Return on equity-16.7%-76.7pp

Debt / equity0×0.0×

Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept bax:ReportingUnitCashFlowPercentageRoyaltyRate.

The official record: Baxter International’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's healthcare systems & technologies — royalty rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Baxter International's healthcare systems & technologies — royalty rate?: Baxter International (BAX) reported healthcare systems & technologies — royalty rate of 3% in Q4 2025.
What does healthcare systems & technologies — royalty rate mean?: The percentage of sales paid to external parties for the right to use their technology or intellectual property.
How do you interpret healthcare systems & technologies — royalty rate?: A rising royalty rate may indicate increasing reliance on third-party technology, which can pressure long-term segment profitability.
How does healthcare systems & technologies — royalty rate compare across companies?: Commonly found in licensing agreements and cost-of-goods-sold analysis for technology-heavy medical device segments.